Article
In vitro characterization of engineered red blood cells as potent viral traps against…
medRxiv · 2020 · Hoffmann, M. A. G.; Kieffer, C.; Bjorkman, P. J.
Key facts
| Title | In vitro characterization of engineered red blood cells as potent viral traps against HIV-1 and SARS-CoV-2 |
|---|---|
| First author | Hoffmann, M. A. G.; Kieffer, C.; Bjorkman, P. J. |
| Journal | medRxiv |
| Published | Dec 21, 2020 |
| DOI | 10.1101/2020.12.20.423607 |
| Product codes mentioned | MVU |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1